Articles by Avacta Group plc

Global distribution agreement with ABCAM plc to sell Avacta’s SARS-CoV-2 research ELISA Affimer reagents

Affimer-based research assay launched alongside performance data published by Bruker

Avacta to make a high performance Affimer research ELISA test available to support global research efforts to combat the coronavirus

Highly specific prototype test detects the virus spike protein at clinically relevant concentrations

Second partnership to exploit the recently generated Affimer binders to the SARS-COV-2 virus in a high throughput COVID-19 antigen test

Avacta successfully generates several highly specific Affimer reagents for COVID-19 antigen rapid test ahead of schedule as part of Cytiva partnership

Partnership to develop and manufacture a rapid test for the COVID-19 coronavirus infection for population screening

Sustained production of Affimer drugs by muscle tissue in vivo could lead to major patient and commercial benefits